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CCTA being widely used in other clinical 
applications such as myocardial function 
or dynamic perfusion.
Recent advance 
The rate of CCTA failure has substan-
tially diminished as a result of recent ven-
dor-specific technological advances in 
temporal, spatial and contrast resolution, 
noise reduction and arrhythmia detec-
tion. Due to these improvements, and de-
spite radiation dose concerns, CCTA may 
yet become the one-shot-stop examina-
tion for both coronary artery disease and 
advanced applications such as perfusion 
assessment. Obviously this prospect 
 warrants further clinical investigation.
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artifacts 
CCTA is technically complex and sub-
ject to constraints that may result in im-
age artifacts. Key factors determining 
CCTA image quality include temporal 
resolution, spatial resolution, contrast 
resolution and noise. 
Artifacts that may reduce image quality 
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Fig. 1. — Cardiac motion-related blurring artifact of the second segment of the right 
coronary artery (arrows in A) due to high heart rate (average heart rate of 75 beats per 
minute in B) in this prospective ECG-triggered acquisition.
Fig. 2. — Stairstep artifacts of the left anterior descending artery (arrows in A) due to 
cardiac arrhythmia (HR between 37 and 51 beats per minute in B) in this prospective 
ECG-triggered acquisition.
Cardiac CT angiography: technical as-
pects in 2012
O. Ghekiere1, A. Nchimi2
With the advent of the multidetector 
computed tomography (CT), cardiac 
computed tomography angiography 
(CCTA) has become a viable non-invasive 
method to rule out obstructive coronary 
artery diseases (CAD) due to its excellent 
negative predictive value. CCTA is mainly 
indicated in those patients presenting 
with clinically low-to-intermediate pretest 
likelihood for CAD. 
Despite its high diagnostic accuracy 
for detection of obstructive coronary ar-
tery disease, insufficient temporal, spatial 
or contrast resolution may sometimes 
provide incomplete or even misleading 
images of some coronary segments. 
These image artifacts are the main cause 
for misinterpretation regarding the pres-
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aortic valve dysfunction. Consequently, 
when a dilated ascending aorta is ob-
served in a young adult, a bicuspid aortic 
valve has to be considered (Fig. 3). Sec-
ondary to wear and tear, a bicuspid valve 
can present with thickened and partially 
calcified cusps at a relatively young age. 
Nevertheless, the amount of calcification 
by itself cannot be adequately used as a 
predictive marker for valve dysfunction 
(Fig. 3). Finally, a bicuspid valve can be 
associated with other congenital anoma-
lies, including an aortic coarcatio.
A morphologically normal aortic root 
incorporates three sinuses of Valsalva of 
equal size and a tricuspid valve. In analo-
gy with the variation in numbers of cusps, 
significant discrepancy in the develop-
ment of these sinuses and cusps can exist 
(Fig. 4). As such, an aortic valve with a 
hypoplastic cusp and associated smaller 
sinus can consequently mimick a ‘true’ 
bicuspid valve (Fig. 5). CT has proven to 
be an excellent tool in the evaluation of 
valve morphology, often acting compli-
mentary to the echocardiography-derived 
evaluation. While magnetic resonance 
(MR) imaging and echocardiography are 
traditionally the methods of choice in the 
evaluation of aortic valve dysfunction, 
several studies have demonstrated the 
ability of ECG-gated CT studies to cor-
rectly assess both aortic valve stenosis 
and regurgitation (Fig. 6). In contrast to 
the mentioned traditional imaging mo-
dalities, this evaluation requires an addi-
tional radiation exposure which can be 
substantial. Therefore, we do not recom-
mend this in routine practice, its use bet-
ter reserved for application on a case-by-
case basis.
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Fig. 1. – The aortic root has a double-oblique orientation, but a rough initial cross-sectional reformation can be obtained by align-
ing the imaging plane in an oblique fashion along the aortic valve cusps (dashed line) on a coronal reformatted image (A). The aortic 
root has three sinuses of Valsalva (asterisk in B), and contains a normally tricuspid aortic valve.
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Imaging of the aortic root and ascend-
ing aorta
R. Salgado, P. M. Parizel1
Introduction
In recent years there has been increas-
ing interest in the non-invasive imaging 
of the aortic root and ascending aorta. 
This is in part due to the exploration of 
the capabilities of CT-imaging in the as-
sessment of the aortic valve, including 
the evaluation of aortic valve stenosis 
and insufficiency. Recent advances in 
transcatheter valve implantation tech-
niques targeted at the aortic valve have 
also spurred interest in the non-invasive 
evaluation of the complex anatomy of the 
aortic root.
Finally, the ascending aorta is a some-
times underestimated source of acute 
chest pain. 
Aortic valve and root
While the aortic valve has traditionally 
three cusps (Fig. 1), many variations can 
exist. Up to 1-2% of the population has a 
bicuspid valve (Fig. 2). Its presence has 
potential important clinical consequenc-
es, as a bicuspid aortic valve is more sus-
ceptible to premature degeneration, and 
is associated with a varying degree of 
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Fig. 2. – Double-oblique reformatted cross-sectional contrast-
enhanced CT image in a 42-year-old man demonstrating the 
typical appearance of a bicuspid aortic valve. Note that there are 
only two sinuses of Valsalva (asterisk). 
Fig. 4. – A 52-year-old man with an acquired functionally bi-
cuspid valve. The cross-sectional reformatted contrast-enhanced 
CT image reveals three sinuses of Valsalva (asterisk), but only 
two cusps. This functionally bicuspid appearance can be the end 
result of fusion between two cusps, in this case secondary to a 
decade-old valve infection. As such, originally tricuspid aortic 
valves can become functionally bicuspid.
Fig. 3. – Coronal contrast-enhanced CT image demonstrating 
a premature degenerated bicuspid valve in a 36-year-old woman 
with extensive valve calcifications and thickened cusps. Note the 
dilated ascending aorta, a common associated finding second-
ary to the hemodynamic effects of aortic valve dysfunction.
Fig. 5. – A 65-year-old man with a hypoplastic left coronary 
cusp on a cross-sectional contrast-enhanced CT image through 
the aortic valve. The hypoplastic left coronary cusp and left sinus 
of Valsalva make this valve appear almost bicuspid. Many varia-
tions exist in the morphology of the aortic valve. While CT can 
deliver excellent image quality, the associated radiation expo-
sure and the lack of true functional information makes it not suit-
able for routine valve evaluation. Consequently, the application 
of CT for the evaluation of valve morphology must be restricted 
on a case-by-case basis, and always in conjunction with the find-
ings of echocardiography and magnetic resonance imaging.
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contrast to the circular contour which 
was always assumed using two-dimen-
sional techniques like echocardiography. 
Current research concentrates, among 
others, in establishing the optimal inte-
gration of different imaging tools for 
achieving optimal transcatheter valve 
size selection for a given patient, and to 
subsequently prevent or minimize para-
valvular regurgitation.
raphy, most notable transesophageal ul-
trasound, has been successfully used in 
different trials for the evaluation of annu-
lar dimensions, it is now widely recog-
nized that the excellent three-dimension-
al capabilities of CT can make a significant 
contribution in optimizing annular sizing. 
Several CT-based studies of the annular 
dimensions have indicated an oval annu-
lar morphology in a majority of cases, in 
Pre-operative evaluation of the aortic 
annulus
With the development of transcatheter 
valve implantation techniques for treat-
ment of critical aortic valve stenosis, con-
siderable attention is currently given to 
the optimal pre-procedural evaluation of 
the aortic annulus dimensions using non-
invasive techniques. While echocardiog-
Fig. 6. – Evaluation of aortic valve stenosis and insufficiency using CT. Panel A illustrates the normal opening of the valve during 
systole. Panel B conversely demonstrates the only slight systolic valve opening in an 82-year-old man with critical aortic valve ste-
nosis. Panel C shows the normal closing of the aortic valve in the end-diastolic phase of the cardiac cycle. Panel D reveals in the same 
cardiac phase a residual opening corresponding with aortic valve insufficiency. Functional aortic valve evaluation is traditionally 
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there is only an entry site in the aortic 
wall, and no detectable re-entry site. Con-
sequently, this stationary blood forms a 
thrombus in the aortic wall, with a ‘false’ 
lumen that is typically semicircumferen-
tial and smaller than the main true lumen. 
It is furthermore important to recog-
nize that this situation can evolve to a 
classic aortic dissection. This can occur 
when one or several re-entry sites devel-
op along the course of the diseased aortic 
wall (Fig. 7). On such occasion, there is 
transition to two channels of flowing 
blood, with often the false lumen having 
a larger cross-sectional diameter than the 
true lumen. 
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 syndrome: discriminating and over-
Acute aortic syndrome
The term ‘acute aortic syndrome’ is 
used to indicate the trilogy of acute aortic 
dissection, intramural hematoma and 
penetrating atherosclerotic ulceration as 
aortic-based causes of acute chest pain. 
However, contemporary criticism points 
out that the distinction between these 
three causes is conceptually flawed, as 
especially acute aortic dissection and in-
tramural hematoma most probably rep-
resent two separate presentations of the 
same clinical entity. Most important, it is 
now preferred to use ‘intramural hema-
toma’ as a descriptive term, indicating 
stationary blood within the aortic wall. 
This stationary blood is formed as blood 
from the main (true) lumen enters the 
aortic wall through a small and often on 
CT or MR imaging unnoticeable defect in 
the intima layer. As is often the case, 
Fig. 7. – Evolution from an intramural hematoma to a classic dissection in a 32-year-old man with acute chest pain. On admission, 
the sagittal contrast-enhanced CT image (A) reveals a clear intramural hematoma (white arrows), with a small entry site (black arrow) 
just distally from the left subclavian artery, and no clear re-entry site. This image shows the clear distinction between one channel of 
flowing blood (large true lumen T), and one channel of stationary blood (intramural hematoma). However, after 6 days a new CT 
examination now shows several entry- and re-entry sites with two channels of flowing blood and a consequently larger false lumen. 
This changed appearance now represents a classic form of (in this case type-B) aortic dissection, and illustrates the varying morphol-
ogy of the acute aortic syndrome.
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ablation can be used to thermally destroy 
atrial foci suspect for initiation of these 
arrhythmias. These procedures are often 
aided by cardiac CT by identifying the ex-
act pulmonary vein anatomy, of which 
there are many variants (large or small 
venoatrial junctions, common ostia or 
 accessory pulmonary veins).
In end-stage heart failure, cardiac re-
synchronization therapy (CRT) has been 
shown to increase survival and provide 
systematic relief of symptoms. This pro-
cedure requires positioning of a pacing 
lead near the inferolateral wall of the LV. 
The main factor determining the success 
of a transvenous LV lead implantation is 
cardiac anatomy, particularly of the coro-
nary venous system, which is known to 
be highly variable. With only a small ad-
aptation of the regular cardiac scanning 
algorithm, many studies have shown reli-
able visualization of the cardiac venous 
anatomy and accurate quantification on 
the dimensions of the ostium of the coro-
nary sinus and the diameter of the target 
veins.
Imaging of myocardial infarction and 
ischemia
Similar to what is more commonly 
performed in an MRI setting, cardiac CT 
can be are acquired during the first pass 
of a bolus of contrast agent, theoretically 
allowing hypoperfused areas within the 
myocardium regions to appear with low 
attenuation. 
Although currently perfusion CT is still 
largely investigational and still under de-
velopment in preclinical animal models, a 
good accuracy to detect myocardial in-
farction has been observed. In similar 
studies, delayed phase scanning showed 
delayed hyperenhancement in the infarct 
area.
schemes only acquire information about 
the second part of the cardiac cycle, thus 
disallowing any functional evaluation. A 
motivated choice has to be made by the 
radiologist, based on the clinical history 
and depending on what information is to 
be gained, whether to choose for a low-
dose scan or a full functional 4D evalua-
tion.
Imaging of cardiac valves
Homologous to the situation described 
for cardiac function, the high spatial reso-
lution allows for detailed analysis of the 
cardiac valves. Cardiac CT provides im-
portant information on the presence of 
(peri)valvular and annular calcifications, 
variations in the number of valve leaflets, 
and recently more specifically on the aor-
tic valve anatomy, geometry, and valve 
area in patients considered for transarte-
rial aortic valve implantation (TAVI) 
(Fig. 1).
In selected cases, imaging of artificial 
valves and assist devices can be consid-
ered, since the new fast acquisition algo-
rithms and artifact-reducing reconstruc-
tion kernels allow accurate anatomical 
and functional visualization in case of 
valve dysfunction.
The exact value of valvular assess-
ment by cardiac CT is largely still under 
investigation, re-emphasized by its grad-
ing in the recent Appropriateness Criteria 
for Cardiac Computed Tomography and 
Cardiac Magnetic Resonance Imaging, 
from the American College of Cardiology, 
as an ‘uncertain indication’ (Fig. 2).
Imaging of the atria and the cardiac 
venous system
In patients with drug-resistant atrial 
 fibrillation, transcatheter radiofrequent 
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Non-coronary applications of cardiac 
CT (with MR correlation)
S. Dymarkowski1
The high diagnostic accuracy and high 
negative predictive value of cardiac mul-
tidetector row computed tomography 
(MDCT) to evaluate coronary artery ste-
noses is very well known, and as such, 
this technique has been put forth as the 
most promising non-invasive exam. 
 Additionally, the full volumetric dataset 
allows for analysis of a wide range of 
other cardiac pathologies. 
Left ventricular volumes and systolic 
function can be accurately assessed, if 
both systolic and diastolic frames are 
 acquired. The same holds true for 
 evaluation of (artificial) cardiac valves. 
Furthermore, accurate high-resolution 
 visualization of the atria, pulmonary veins 
and the cardiac venous system is often 
sought by the cardiologist performing 
electrophysiological procedures.
The newest technological advances 
 allow these exams to be performed at 
relatively low radiation doses. This brings 
novel applications such as stress- 
perfusion imaging and cardiac dual 
 energy imaging into the picture and 
opens the door towards CT imaging of 
myocardial infarction and ischemia.
Cardiac function assessment
Assessment of global systolic function 
can be achieved by reconstructing a 4D 
retrospective gated spiral acquisition in 
different phases throughout the cardiac 
cycle (typically a phase every 10% of the 
RR interval) to identify end-diastolic and 
end-systolic phases. By delineating the 
endocardial surface and by using the 
Simpson method, the LV volumes are ob-
tained. The accuracy of MDCT-derived 
functional parameters has been exten-
sively investigated and compared with 
other imaging modalities such as gated 
single-photon emission computed to-
mography (SPECT) and magnetic reso-
nance imaging (MRI) and has been found 
to be both a very reproducible and accu-
rate means to quantify LV volumes and 
LV ejection fraction.
In recent years however, the habit of 
obtaining retrospectively gated scans has 
strongly declined, since newer acquisi-
tion algorithms such as the ‘step and 
shoot’ prospective gating method and 
the emergence of single heartbeat acqui-
sitions have allowed for a dramatic de-
crease in radiation dose, but these 
Fig. 1. — Circulite left ventricular assist device. 3D VRT recon-
struction of the in- and outflow canullae.
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pericardial disease on diastolic function, 
or the functional significance of pericar-
dial thickening are rarely assessable by 
CT, where this is rather comfortably done 
in echocardiography and cardiac MRI.
Conclusions
Cardiac CT can be considered as a 
valuable non-invasive imaging modality 
for the study of different non-coronary 
cardiac diseases. The ability to perform 
high quality functional analyses of ven-
tricular and valvular function has been 
extensively proven, but must be looked at 
skeptically, since this comes at a signifi-
cant cost in terms or radiation dose.
Cardiac CT is also being increasingly 
solicited as the preferred modality for 
planning of different minimally invasive 
procedures, such as transcatheter ablation 
of arythmogenic foci within the atria or 
TAVI and CRT implantations.
The use of CT for investigation of 
 myocardial scar formation and ischemia 
visualization is still in its investigational 
phase. 
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of atrial fibrillation and adjacent to areas 
of infarction tissue in patients with isch-
emic heart disease. These thrombi ap-
pear as non-attenuating mural masses, 
usually in high contrast to the iodine 
within the cardiac chambers. Other mass-
es, such as primary and secondary tu-
mors, or mimics of normal anatomy, may 
be readily detected by CT, but may prove 
to be difficult to characterize (Fig. 3). In 
these cases MRI is the preferred imaging 
modality since its multiparametric ap-
proach allows for more accurate tissue 
characterization.
Pericardial diseases, expressed as fo-
cal or generalized thickening, contrast en-
hancement in inflammatory conditions 
and calcifications in more chronic set-
tings are easy to investigate with cardiac 
CT, especially in scenarios where echo-
cardiography is known to underperform, 
e.g. poor acoustic window due to consti-
tution or in the immediate postoperative 
setting. Nevertheless, the influence of 
A significant coronary stenosis will 
usually not show any signs of decreased 
perfusion in a resting state. Therefore, 
also the feasibility of performing adenos-
ine or dipyridamole stress myocardial 
perfusion imaging has been explored and 
has shown potential to provide informa-
tion on stress-induced ischemia in select-
ed patients. Issues of patient safety, unfa-
miliarity with monitoring requirements 
and difficulties in acquiring reliable data 
in patients with drug induced tachycardia 
during CT have so far limited its wide 
spread use in clinical practice.
Imaging of myocardial masses and peri-
cardial diseases
A cardiac mass can often be detected 
as an incidental finds on cardiac CT per-
formed for other indications. The majori-
ty of these lesions are cardiac thrombi, 
usually located in the left atrium or left 
atrial appendage in patients with history 
Fig. 3. — Short-axis (left) and transverse (right) CT image of a cardiac lipoma, arising 
from the inferobasal interventricular septum.
Fig. 2. — Systolic (A) and diastolic (B) image of an artificial mitral valve that shows absence of proper opening of the posterior 
leaflet.
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tain” in presence of low pre-test probabil-
ity and “appropriate” in patients with in-
termediate and high pre-test likelihood 
(evidence level 7 out of 9 for both) exclud-
ing subjects with ST-segment elevation 
and/or positive cardiac enzymes in which 
examination was considered inappropri-
ate (6). 
A similar consensus was recently re-
ported by the Italian sub society of cardi-
ac radiology in which use of CCTA in pa-
tients with non-assessable ECG and /or 
equivocal laboratory biomarkers was 
scored as class II clinical indication (i.e. 
diagnostic information of clinical rele-
vance provided) in presence of ACP 
whereas the triple rule out protocol appli-
cation was regarded as potentially useful 
but still investigational (7).
The “Triple Rule Out” Protocol
Ideal CCTA protocol should represent 
the best compromise between the need 
for a comprehensive and reliable evalua-
tion of all thoracic cardiovascular struc-
tures at the lowest radiation dose possible.
Recent technological advances enable 
an accurate and detailed imaging of coro-
nary arteries, thoracic aorta and pulmo-
nary arteries in a single contrast-en-
hanced ECG-gated CT scan. 
Although the examination is poten-
tially feasible even on 16-slice CT scan-
ner, it is recommended to use last gener-
ation machines (64-slice or greater) 
implemented by radiation dose reduction 
tools and dedicated cardiac post-process-
ing software.
Use of a preliminary unenhanced pro-
spectively ECG-gated acquisition cover-
ing the entire thoracic aorta might be 
helpful to provide information regarding 
distribution and amount of coronary ar-
tery calcium and to eventually detect hy-
perdense vascular rims reflecting intra-
mural aortic hematoma at the cost, 
however, of an increased patient’s expo-
sure.
The choice to apply retrospective or 
prospective ECG-synchronization tech-
niques is conditioned by the available 
technology and patient’s heart rate, keep-
ing in mind the general concept that the 
combination of a stable and sinus heart 
rhythm and a heart rate of less than 65-70 
beats per minute (depending on the scan-
ner generation) is mandatory to obtain 
adequate image quality.
Radiation doses of retrospectively gat-
ed 64-slice CT range between 7 to 14 mSv 
when dose modulation strategies are ap-
plied whereas in prospectively ECG-gat-
ed triggering, a significant effective dose 
reduction is realistically feasible with a 
dose of 5 to 7 mSv, less than that from 
nuclear myocardial perfusion imaging. 
Recently, a high pitch dual-spiral cardio-
thoracic comprehensive protocol using a 
last generation dual source CT scanner 
has been proposed in patients with undif-
ferentiated acute chest pain, allowing to 
minimize patient’s individual exposure to 
an average 3.8 mSv.
Heart-rate control can be achieved in 
most of the cases intravenously adminis-
tering a short-acting beta-blocker (like 
4-8% of patients with myocardial infarc-
tion or acute coronary syndrome who are 
inappropriately discharged from the ED 
due to the presence of normal initial car-
diac enzyme levels associated with non-
diagnostic/non-specific electrocardio-
graphic (ECG) and echocardiographic 
alterations (2).
Furthermore, the growing pressure of 
legal disputes for malpractice and the 
reasonable clinical caution in excluding 
potentially lethal syndrome is a common 
cause of unnecessary diagnostic proce-
dures and precautionary prolonged hos-
pitalization with obvious economical im-
plications.
Although an acute coronary syndrome 
is ultimately diagnosed in only 10 to 15% 
of patients who present with ACP, it has 
been estimated that the mean length of 
hospitalization is 4.6 days, with an aver-
age cost of approximately $23,000 per 
patient in the US an annual cost over $3 
billion (3).
Primary objectives of social health 
systems in Europe and US are to speed-
up diagnostic algorhythm, improve diag-
nostic accuracy and, obviously, reduce 
management costs.
In this clinical setting, contrast-en-
hanced coronary computed tomographic 
angiography (CCTA) has emerged as a 
promising non-invasive diagnostic tool, 
with an high sensitivity and specificity 
and a ~100% negative predictive for the 
exclusion of coronary artery disease, po-
tentially allowing to improve clinical care 
of those patients.
A role of CCTA in supporting the triage 
of patients with suspected acute coronary 
syndrome has been hypothesized since 
early 2000’ (4) and its impact on costs and 
health care has been subject of an exten-
sive recent literature, nevertheless unani-
mous consensus was not achieved. 
In particular, great emphasis was 
 given to the so-called “triple rule out” 
protocol that offers in one-stop-shop 
exam a complete evaluation of thoracic 
cardiovascular structure, revealing three 
severe acute potentially lethal disorders 
(ischemic heart disease, acute aortic 
 disease or pulmonary embolism).
Present article will discuss different 
acquisition protocols, clinical results and 
economical implications of CCTA in the 
clinical setting of ACP.
Clinical indications
According to current American Heart 
Association (AHA) guidelines, appropri-
ateness of CCTA in patients presenting 
with symptoms of ACP has been indicat-
ed as “uncertain” in both patients pre-
senting with persistent ECG ST-segment 
elevation following exclusion of myocar-
dial infarction or with ACP of uncertain 
cause (score 6 out of 9 for both indica-
tions) and inappropriate in presence of a 
definite diagnosis of myocardial infarc-
tion (5).
The Asian Society of Cardiovascular 
Imaging (ASCI) guidelines, categorized 
clinical appropriateness to the exam ac-
cording to pre-test probability of disease. 
Use of CCTA was indicated as “uncer-
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Acute chest pain and CT: current in-
sights & cost-effectiveness
M. Francone, N. Galea, R. Rosati,  
I. Carbone1
Acute chest pain (ACP) is a common 
reason of admission at the emergency 
departments (ED), not infrequently repre-
senting a source of challenging dilemmas 
for clinicians and anxiety for patients with 
relevant legal implications related to in-
appropriate therapeutic management (1).
The list of differential diagnosis of ACP 
is extensive and ranges from benign 
musculoskeletal disorders to life-threat-
ening conditions requiring immediate 
treatment such as acute coronary syn-
drome, aortic dissection, rupture of the 
esophagus, perforating peptic ulcer, 
 pulmonary embolism and tension 
pneumo thorax.
Current diagnostic algorithms may re-
liably rule out serious disorders in most 
of the cases however there is still persis-
tence of an unacceptable rate of about 
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Main findings emerged from literature 
were the following:
1) Use of CCTA allows a higher rate of pa-
tient’s discharge from ER with a short-
er length of stay as compared to the 
standard of care (SOC) (14). Litt and 
colleagues (3) reported a remarkable 
27% difference in the rate of early dis-
charge of patients who underwent 
CCTA as compared to SOC with a sig-
nificantly reduced median length of ER 
stay of 18.0 hours vs 24.8 hours. Similar 
results were found in a large metanaly-
sis of four large trials reported reporting 
a significant reduction patient’s stay, 
including both ED or total hospital 
stay (15).
2) The majority of authors found a cost 
saving ranging between 15% and 38% 
when use of CCTA was compared to 
perfusion imaging as reference stan-
dard (12).
Moreover, detection of regional myo-
cardial perfusion defect has an additional 
diagnostic value to CCTA, reducing rates 
of false positive an improving the posi-
tive predicting value from 67% to 90.1%, 
if compared to rest sestamibi single-pho-
ton emission CT myocardial perfusion 
imaging (SPECT-MPI) (13).
Cost-effectiveness
Analysis of CCTA cost-effectiveness in 
the clinical setting of ACP has been a sub-
ject of interest in a large number of re-
cently published papers, either based on 
simulated models of clinical and econom-
ic outcomes and on large patient’s co-
horts or metanalysis.
metoprolol 5-20 mg or esmolol 10 mg/
mL) few minutes prior to the examination 
excluding patients with general contrain-
dications to the drug (asthma, sinus bra-
dycardia and hypotension, atrioventricu-
lar block etc). Preliminary administration 
of sublingual nitroglycerin could also be 
useful to dilate coronary arteries.
Test bolus or bolus tracking protocol 
are strongly advisable to determine the 
optimal timing of contrast injection and 
when bolus tracking is selected we sug-
gest to use a threshold of 120-140 HU and 
a region of interest placed within the as-
cending aorta. Contrast medium adminis-
tration protocol should be adapted to the 
covered surface of body, however a bolus 
of 80–110 mL of contrast medium at a 
rate of 4-5.0 mL/s followed by a 40 mL 
 saline flush is usually adequate to obtain 
an optimal vascular enhancement within 
the entire acquisition window.
Further technical aspects about the CT 
scan protocol are provided in a large 
 expert consensus recently published (8).
Images interpretation 
Radiological report of patients admitted 
with ACP should be promptly prepared 
and communicated to the referring clini-
cal team of the ED in order to speed-up 
diagnostic workup; utilization of a pre-
filled initial and final patient’s report form 
has even been suggested on this re-
gard (4).
A complete evaluation of both cardiac 
and non-cardiac structures needs to be 
provided, to rule out pulmonary embolism 
and aortic dissection and to exclude non-
vascular causes of chest pain potentially 
affecting patient’s management (eg. 
pneumotorax, pneumonia, pleural or 
peri cardial effusion).
Coronary arteries evaluation should 
include detailed description of location, 
extent and morphological features of 
plaques, with particular attention to soft 
density lesions and to the so-called 
 “napkin-ring sign” with is characterized 
by the presence of a ringlike attenuation 
pattern resembling the thin-cap fibroath-
eroma recognized as a precursor lesion 
for plaque rupture (9) (Fig. 1).
A strong prognostic value of CCTA 
was recently demonstrated, independent 
of traditional risk factors and calcium 
scoring, in a patient’s cohort of 457 sub-
ject presenting with ACP in which the ab-
sence of plaques was associated with no 
clinical event in a follow-up period of 11 
months (10).
Comprehensive cardiac evaluation 
should combine morphological informa-
tion obtained from coronary arteries 
analysis with functional (ejection fraction, 
regional wall motion) and perfusional 
data, in order to correlate non-invasive 
angiographic findings with status of cor-
responding vascular territory (Fig. 2) (11).
Combined evaluation of regional wall 
motion abnormalities and myocardial 
perfusion defects has shown to improve 
detection of acute myocardial infarction 
with a sensitivity of 94% and specificity of 
97%, using cardiac biomarkers and single 
photon emission CT (SPECT) myocardial 
Fig. 1. — CCTA in a 63-year-old patient admitted at the ER due to recent atypical an-
gina, presenting with negative ECG and enzymes. Curved planar reconstruction show 
the presence of an eccentric soft tissue lesion located in mid left anterior descending 
artery, causing moderate luminal stenosis (A). An high grade lesion is also located at 
the origin of left posterior descending artery (C) and was successfully treated with cor-
onary stenting. Corresponding selective coronary angiography images are displayed in 
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Conclusions
The very high negative predictive 
 value of CCTA for CAD minimizes risk of 
undetected acute coronary syndromes 
providing relevant impact on patient’s 
prognosis and clinical management (3, 
16). 
CCTA in ACP is a fast, feasible, and ro-
bust imaging technique which is becom-
ing widely available in the ER with an ac-
ceptable dose exposure when using last 
generation scanners combined with ap-
propriate dose reduction strategy. It al-
lows a rapid patient’s discharge with sig-
nificant health-care costs reduction and 
improved individual therapeutic manage-
ment.
On the other hand, the presence of an 
high-grade stenosis does not necessarily 
reflect an acute coronary syndrome and 
non-invasive angiographic findings should 
be necessarily combined with comple-
mentary functional/perfusional tests to 
rule-out underlying myocardial ischemia 
due to the assumption that coronary 
physiology is the critical decision point 
for consideration of revascularization.
Additional limitations to widespread 
utilization of CCTA in this setting rely on 
the current limited availability of dedicat-
ed cardiac imaging specialist and on the 
still high number of false positive cases 
related to the presence of extensive vas-
cular calcifications with intraluminal 
beam hardening artifacts.
The future is anyway probably going 
in the direction of CCTA as acknowledged 
by clinical guidelines and appropriate-
ness criteria of the main national and in-
ternational medical societies and wit-
nessed by the extensive literature 
vs 1,397 undergoing SOC, with subse-
quent cost increase of 3.9% in case of 
hospitalization of CCTA patients (17). 
In positive CCTA patients, therefore, 
the increase of downstream testing 
and procedures may cause a cumula-
tive mean cost of care similar to the 
SOC group.
SOC, mostly in patients with low- to 
intermediate-risk of disease (14-16) 
(Fig. 3).
3) CCTA allows higher detection of coro-
nary arteries disease with subsequent 
increase of percutaneous and stenting 
procedures as emerged from the 
pooled data of a large study popula-
tion 1,869 patients undergoing CCTA 
Fig. 2. — Left anterior descending artery post-traumatic focal dissection in a 26-year-old patient following a 
severe motorbike accident (A). Corresponding thin-slice volume rendering reconstruction shows the presence 
of a large perfusion defect located in the mid anterior-septal left ventricular wall perfectly matching distribution 
territory of the dissected vessel (B, arrows).
Fig. 3. — Bar chart showing analysis of CCTA cost effective-
ness compared to standard of care. Data are plotted from refer-
ence #15 and derived from the metanalysis of 4 large clinical 
trials focused on patients with ACP. ROMICAT II study results are 
differentiated in discharged (ER only) vs hospitalized (hosp) 
 patients.
A B
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Heart valve disease (stenosis or insuf-
ficiency) is common and affects mainly 
the aortic and mitral valve. There is no 
known method (medication, lifestyle or 
otherwise) that halts or reverses the dis-
ease process. If the is valve severely ste-
notic or insufficient, heart valve replace-
ment (or repair in case of mitral valves) 
with a PHV is inevitable (1). 
Two types of prosthetic heart valves 
are used: mechanical and biological PHV. 
Mechanical PHV are composed of metal 
alloys and/or carbon whereas biological 
PHV are composed of pericardium or ani-
mal tissue. Biological PHV do often have 
a supporting frame work that contains 
metal elements. Mechanical PHV are de-
signed to last lifelong but also require 
lifelong anticoagulation therapy. Biologi-
cal PHV have the advantage of being 
much less thrombogenic and thus do not 
require anticoagulation. However, they 
are prone to wear and have a limited (10-
20 years) lifespan.
Although often being a lifesaving 
 intervention, having a PHV presents the 
patient with a chronic disease with 
 associated morbidity (bleeding due to 
 anticoagulation, endocarditis and pros-
thesis dysfunction) and reduced life 
 expectancy (1). Other modes of PHV 
 dysfunction include obstruction by 
 pannus formation underneath the PHV 
and thrombosis. 
Echocardiography and fluoroscopy 
(for mechanical PHV) are the techniques 
used for PHV assessment (1, 2). Unfortu-
nately they are often unable to determine 
the cause of PHV dysfunction (2). There is 
a role for cardiac CT to assess PHV and 
determine the cause of dysfunction as a 
complementary technique to echocardio-
graphy and fluoroscopy (3, 4).
PHV imaging by CT
Image quality
In the last 5 years the abilities of CT for 
PHV assessment have become subject of 
intense research. Our own research line 
on PHV imaging combines in-vitro and 
patient studies. The in-vitro studies use a 
dedicated perfusion set-up to optimize 
scan protocols aimed to reduce radiation 
exposure and at the same time reduce 
PHV induced artefacts. 
Using this set-up we have demonstrat-
ed that most PHV types generate only a 
limited amount of artefacts and have a 
good image quality on CT (Figure 1) (5). 
Artefacts can be reduced using prospec-
tive acquisitions, higher KV settings and 
iterative reconstruction (6-8). Only Bjork 
Shiley and Sorin mono leaflet PHV that 
contain cobalt chromium generate exten-
sive artefacts that prohibits assessment 
with CT (3,5).
Obstructive dysfunction
Obstructive dysfunction of a PHV man-
ifests itself as an increased pressure 
 gradient over the PHV on echocardiogra-
phy (1, 2). The most important etiologies 
that need to be differentiated between 
are pannus, thrombus and patient pros-
thesis mismatch. The latter is basically 
strongly supporting its utilization in large 
clinical trials.
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Conclusion
PHV assessment is a promising new 
application for cardiac CT that can pro-
vide complementary information to echo-
cardiography and fluoroscopy. CT can be 
especially valuable to determine the 
cause of obstructive PHV dysfunction and 
determine the extent of PHV endocarditis.
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too small a PHV for the size of the patient 
and is a diagnosis by exclusion. Differen-
tiation between thrombus and pannus is 
difficult by echocardiography but clini-
cally extremely important (2). Pannus re-
quires reoperation whereas thrombosis 
can be treated with thrombolysis. CT is 
able to visualize both pannus and throm-
bus and the location of the lesion can be 
used to discriminated between both (9). 
However, no data on the diagnostic accu-
racy of CT is available from large patient 
series yet. 
Endocarditis
Endocarditis is an especially devastat-
ing complication after PHV implantation 
that is associated with high mortality and 
morbidity. CT is helpful to establish the 
presence and extent of periannular com-
plications such as mycotic aneu-
rysms (10). Due to the complex anatomy, 
CT has an advantage over echocardiogra-
phy due to its ability to reconstruct imag-
es in any desired imaging plane. This in-
formation can be vital to the surgeon to 
optimize pre-operative planning. 
Guidelines
So what are the current recommenda-
tions for the use of CT for PHV assess-
ment? The 2010 appropriate use criteria 
state that the use of CT is appropriate for 
“Characterization of prosthetic cardiac 
valves” (11): In the most recent ESC 
guideline on valvular heart disease the 
authors state: “CT provides useful addi-
tional information if valve thrombus or 
pannus are suspected (1). In our review 
article (4) we propose a flowchart for the 
use of CT depending on the specific etiol-
ogy of PHV dysfunction.
Fig. 1. — Volume rendered CT images of a bileaflet Carbo-
medics PHV and a monoleaflet Medtronic Hall PHV. 
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